4-Heptanone is a metabolite of the plasticizer di(2-ethylhexyl) phthalate (DEHP) in haemodialysis patients

Nephrology Dialysis Transplantation

Volumn 19, Issue 10, 2004, Pages 2576-2583

  Wahl, Hans Günther ^a   Hong, Qunfa ^b   Hildenbrand, Sibylle ^b   Risler, Teut ^b   Luft, Dieter ^b   Liebich, Hartmut ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

4 heptanon; DEHP; Diabetes mellitus; Haemodialysis; In vivo metabolism

Indexed keywords

2 ETHYLHEXANOIC ACID; 4 HEPTANONE; DRUG METABOLITE; GLUCOSE; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PLASTICIZER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GAS CHROMATOGRAPHY; GLUCOSE BLOOD LEVEL; HEMODIALYSIS; HUMAN; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STRUCTURE ANALYSIS; URINALYSIS;

ADULT; AGED; CASE-CONTROL STUDIES; DIABETES MELLITUS; DIETHYLHEXYL PHTHALATE; FEMALE; HUMANS; KETONES; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; RENAL DIALYSIS;

EID: 5444238373     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh425     Document Type: Article

References (24)

1. Wahl HG, Hoffmann A, Haring HU, Liebich HM. Identification of plasticizers in medical products by a combined direct thermodesorption-cooled injection system and gas chromatography-mass spectrometry. J Chromatogr A 1999; 847: 1-7
2. Jaeger RJ, Rubin RJ. Contamination of blood stored in plastic packs. Lancet 1970; 2: 151
3. Nassberger L, Arbin A, Ostelius J. Exposure of patients to phthalates from polyvinyl chloride tubes and bags during dialysis. Nephron 1987; 45: 286-290
4. Mettang T, Fischer FP, Dunst R, Kuhlmann U, Rettenmeier AW. Plasticizers in renal failure: aspects of metabolism and toxicity. Perit Dial Int 1997; 17 [Suppl 2]: S31-S36
5. Doull J, Cattley R. Elcombe C et al. A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines. Regul Toxicol Pharmacol 1999; 29: 327-357
6. Tickner JA, Schettler T, Guidotti T, McCally M, Rossi M. Health risks posed by use of di-2-ethylhexyl phthalate (DEHP) in PVC medical devices: a critical review. Am J Indust Med 2001; 39: 100-111
7. Ferruti P, Mancin I, Ranucci E, De Felice C, Latini G, Laus M. Polycaprolactone-poly(ethylene glycol) multiblock copolymers as potential substitutes for di(ethylhexyl) phthalate in flexible poly(vinyl chloride) formulations. Biomacromolecules 2003; 4: 181-188
8. Mettang T, Pauli-Magnus C, Alscher DM et al. Influence of plasticizer-free CAPD bags and tubings on serum, urine, and dialysate levels of phthalic acid esters in CAPD patients. Perit Dial Int 2000; 20: 80-84
9. Mitchell AM, Lhuguenot JC, Bridges JW, Elcombe CR. Identification of the proximate peroxisome proliferator(s) derived from di(2-ethylhexyl) phthalate. Toxicol Appl Pharmacol 1985; 80: 23-32
10. Maloney EK, Waxman DJ. Trans-activation of PPAR alpha and PPAR gamma by structurally diverse environmental chemicals. Toxicol Appl Pharmacol 1999; 161: 209-218
11. Rothenbacher KP, Kimmel R, Hildenbrand S, Schmahl FW, Dartsch PC. Nephrotoxic effects of di-(2-ethylhexyl)-phthalate (DEHP) hydrolysis products on cultured kidney epithelial cells. Hum Exp Toxicol 1998; 17: 336-342
12. Albro PW. The metabolism of 2-ethylhexanol in rats. Xenobiotica 1975; 5: 625-636
13. Dirven HA, van den Broek PH, Jongeneelen FJ. Determination of four metabolites of the plasticizer di(2-ethylhexyl)phthalate in human urine samples. Int Arch Occup Environ Health 1993; 64: 555-560
14. Liebich HM, Al Babbili O. Gas chromatographic-mass spectrometric study of volatile organic metabolites in urines of patients with diabetes mellitus. J Chromatogr 1975; 112: 539-550
15. Zlatkis A, Bertsch W, Lichtenstein HA et al. Profile of volatile metabolites in urine by gas chromatography-mass spectrometry. Anal Chem 1973; 45: 763-767
16. Liebich HM, Woll J. Volatile substances in blood serum: profile analysis and quantitative determination. J Chromatogr 1977; 142: 505-516
17. Wahl HG, Luft D, Risler T, Liebich HM. Identification of in vivo DEHP metabolites in breath, plasma and urine of dialysis patients. Nephrol Dial Transplant 1997; 12: A6 [abstract]
18. Wahl HG, Risler T, Luft D, Dartsch PC, Liebich HM. 4-Heptanone is a major metabolite of the plasticiser di(2-ethylhexyl) phthalate (DEHP) in humans. Nephrol Dial Transplant 2002; 17 [Suppl 1]: 292 [abstract]
19. Wahl HG, Hoffmann A, Luft D, Liebich HM. Analysis of volatile organic compounds in human urine by headspace gas chromatography-mass spectrometry with a multipurpose sampler. J Chromatogr A 1999; 847: 117-125
20. Wahl HG, Hong Q, Stube D, Maier ME, Haring HU, Liebich HM. Simultaneous analysis of the di(2-ethylhexyl)phthalate metabolites 2-ethylhexanoic acid, 2-ethyl-3-hydroxyhexanoic acid and 2-ethyl-3-oxohexanoic acid in urine by gas chromatography-mass spectrometry. J Chromatogr B 2001; 758: 213-219
21. Mettang T, Thomas S, Kiefer T et al. Uraemic pruritus and exposure to di(2-ethylhexyl) phthalate (DEHP) in haemodialysis patients. Nephrol Dial Transplant 1996; 11: 2439-2443
22. Walker V, Mills GA. Urine 4-heptanone: a beta-oxidation product of 2-ethylhexanoic acid from plasticisers. Clin Chim Acta 2001; 306: 51-61
23. Schmid P, Schlatter C. Excretion and metabolism of di(2-ethylhexyl)phthalate in man. Xenobiotica 1985; 15: 251-256
24. Melnick RL. Is peroxisome proliferation an obligatory precursor step in the carcinogenicity of di(2-ethylhexyl)phthalate (DEHP)? Environ Health Perspect 2001; 109: 437-442